Oncogene - Table of Contents alert Volume 30 Issue 49

TABLE OF CONTENTS Volume 30, Issue 49 (December 2011) In this issue Original Articles Short Communication Also new AOP Advertisement See the Light. Make the Switch. Stop Cloning! The LightSwitch Luciferase Assay System provides everything you need for reporter assays: pre-cloned human promoters and 3'UTRs in luciferase reporter vectors plus optimized luciferase reagents to measure promoter induction and miRNA target validation. Visit SwitchGear Genomics and explore our genome-wide collections and validated pathway sets. Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement IBMS BoneKEy comes to Nature Publishing Group January 2012 Promoting bone health worldwide with: BoneKEy Knowledge Environment - the premier bone health online knowledge environment delivering extensive coverage on bone diseases and the clinical care of such diseases. BoneKEy Reports - A new online only journal providing in depth coverage of the bone field.   Original Articles Top Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growth K Taniuchi, R L Cerny, A Tanouchi, K Kohno, N Kotani, K Honke, T Saibara and M A Hollingsworth Oncogene 2011 30: 4843-4854; advance online publication, May 30, 2011; 10.1038/onc.2011.194 Abstract | Full Text Phosphorylation and interaction of myopodin by integrin-link kinase lead to suppression of cell growth and motility in prostate cancer cells Y-P Yu and J-H Luo Oncogene 2011 30: 4855-4863; advance online publication, June 6, 2011; 10.1038/onc.2011.200 Abstract | Full Text Pdcd4 directly binds the coding region of c-myb mRNA and suppresses its translation P Singh, L Wedeken, L C Waters, M D Carr and K-H Klempnauer Oncogene 2011 30: 4864-4873; advance online publication, June 6, 2011; 10.1038/onc.2011.202 Abstract | Full Text ABCG2 is a direct transcriptional target of hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell lymphoma R R Singh, K Kunkalla, C Qu, E Schlette, S S Neelapu, F Samaniego and F Vega Oncogene 2011 30: 4874-4886; advance online publication, May 30, 2011; 10.1038/onc.2011.195 Abstract | Full Text SPARC functions as an anti-stress factor by inactivating p53 through Akt-mediated MDM2 phosphorylation to promote melanoma cell survival N Fenouille, A Puissant, M Tichet, G Zimniak, P Abbe, A Mallavialle, S Rocchi, J-P Ortonne, M Deckert, R Ballotti and S Tartare-Deckert Oncogene 2011 30: 4887-4900; advance online publication, June 20, 2011; 10.1038/onc.2011.198 Abstract | Full Text C/EBP-δ regulates VEGF-C autocrine signaling in lymphangiogenesis and metastasis of lung cancer through HIF-1α Y Min, S Ghose, K Boelte, J Li, L Yang and P C Lin Oncogene 2011 30: 4901-4909; advance online publication, June 13, 2011; 10.1038/onc.2011.187 Abstract | Full Text Short Communication Top A novel oncogenic mechanism in Ewing sarcoma involving IGF pathway targeting by EWS/Fli1-regulated microRNAs E L McKinsey, J K Parrish, A E Irwin, B F Niemeyer, H B Kern, D K Birks and P Jedlicka Oncogene 2011 30: 4910-4920; advance online publication, June 6, 2011; 10.1038/onc.2011.197 Abstract | Full Text Advertisement Take a look at this recent article published in Cancer Gene Therapy: Neoadjuvant in situ gene-mediated cytotoxic immunotherapy improves postoperative outcomes in novel syngeneic esophageal carcinoma models OPEN J D Predina, B Judy, L A Aliperti, Z G Fridlender et al. Cancer Gene Therapy doi:10.1038/cgt.2011.56   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2011 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.